IRIS
CORVO', RENZO GIACINTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.856
Totale 28.856
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 28.856
Totale 28.856
Salva come PNG Salva come JPEG
Città #
Genova 21.738
Rapallo 3.450
Genoa 2.596
Vado Ligure 1.022
Bordighera 50
Totale 28.856
Salva come PNG Salva come JPEG
Nome #
Helical Tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant 150
Image guided hypofractionated radiotherapy by helical tomotherapy for prostate carcinoma: toxicity and impact on Nadir PSA. 145
Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck : technical methodology and preliminary results. 136
2.Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 136
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 133
Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT). 129
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 128
Advances in the implementation of helical tomotherapy-based total marrow irradiation with a novel field junction technique. 128
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. 128
Preoperative chemotherapy and radiotherapy in the management of epidermoid carcinoma of the anal canal. 126
Sequential vs alternate chemo-radiotherapy in advanced head and neck tumors. Report on a randomized study. 125
The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy. 124
Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse. 124
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects. 123
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation. 123
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes 123
Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control 123
Long-term survival in a patient with head and neck paraganglioma treated with tailored modalities for 20 years: A case report 121
Cetuximab and Radiotherapy versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer : A Randomized Phase II trial 120
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019 119
Rete HTA- Regione Liguria - Criteri per l'appropriatezza allocativa di alcune apparecchiature - Volume 1 Acceleratori Lineari -LINAC 118
Biological and clinical implications for multimodality treatment in patients affected by squamous cell carcinoma of the head and neck. 118
Feasibility of helical tomotherapy for radical dose retreatment in pelvic area: a report of 4 cases. 117
Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer. 116
Comparison of local recurrence among early breast cancer patients treated with electron intraoperative radiotherapy vs hypofractionated photon radiotherapy an observational study 116
On the delineation of the gross tumor volume and clinical target volume for head and neck squamous cell carcinomas. 115
Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas. 114
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study. 114
Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report 114
Brachiterapia guidata dalle Immagini (MRI) nel carcinoma della cervice localmente avanzato: esperienza mono-istituzionale con 5 anni di follow-up 114
In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. 113
Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study. 113
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 113
Kinetic cell analysis by in vivo bromodeoxyuridine in squamous head and neck cancers: a tool for the radiotherapist. 112
Endothelial cells increase the radiosensitivity of oropharyngeal squamous carcinoma cells in collagen gel 112
Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients. 111
Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck. 111
Reduction Mammaplasty and Intra-Operative Radiotherapy (IORT) in Conservative Surgery 111
New experience with breast volumetric modulation arc therapy (VMAT) realized with Trilogy Linac:comparison with Tomotherapy, Pros and Cons 111
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 111
Total body irradiation before allogeneic and autologous bone marrow transplantation: a ten year Genoa experience. 110
Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. 110
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019. 110
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study 108
Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer 108
Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. 107
Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. 107
Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. 106
Bone marrow transplantation (BMT) for acute nonlymphoid leukemia (ANLL) in first remission. 106
Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. 106
Abdomino-pelvic radiotherapy (moving strip technique) after polichemotherapy with cisplatinum (CDDP) and second look laparatomy. Pilot study in advanced ovarian cancer. 106
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 106
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 106
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. 105
Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey 105
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation. 105
Radiation-induced emesis: a prospective observational multicenter italian trial 104
Tossicità acuta e tardiva correlata a radioterapia ipofrazionata dopo chirurgia conservativa associata o meno a chemioterapia adiuvante per neoplasia mammaria in stadio iniziale: boost IORT versus Concomitant boost 104
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. 103
48: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. 103
Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer 103
Accelerated partial breast irradiation via the mammosite catheter: preliminary reports of a single-institution experience. 102
Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity. 102
Management of Nasal Septum Chondrosarcoma Occurring in Elderly: A Case Report 102
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda 102
Circulating lymphocyte subsets after total lymphoid irradiation in chronicprogressive multiple sclerosis. 101
Excellent survival regardless of disease stage in patients with advanced nasopharyngeal cancer 101
Treatment of nasopharyngeal carcinoma: state of the art and new perspectives (review). 101
Retinoic acid modulates the radiosensitivity of head-and-neck squamous carcinoma cells grown in collagen gel. 100
Chemo-radiation association in head and neck squamous cell carcinoma: Evidences and criticisms 100
Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters 100
Altered fractionation Radiotherapy or radiochemotherapy for patients with HNSCC: impact of meta-analysis results on clinical results. 99
Postoperative radiotherapy for head and neck squamous cell carcinomas: feasibility of a biphasic accelerated treatment schedule. 98
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 98
New chemoradiotherapy combinations in head and neck cancer. 97
Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant. 97
Hamming clustering techniques for the identification of prognostic indices in patients with advanced head and neck cancer treated with radiation therapy. 97
Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib : an expert panel consensus. 97
The vicious Circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 97
Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis 97
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 97
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 96
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence 96
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. 95
Tissue air ratio in total body irradiation. An in vivo evaluation. 95
Co-culture with human fibroblasts increases the radiosensitivity of MCF-7 mammary carcinoma cells in collagen gels. 95
Biological predictors of response to radiotherapy in head and neck cancer: recent advances and emerging perspectives. 94
Lack of a time-factor in alternating chemoradiotherapy for advanced head and neck squamous cell carcinoma. 94
Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: Impact on late toxicity 94
Evaluation of 3-D radiotherapy plans: radiobiological aspects. 93
Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome 93
Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: Review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. 92
Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases. 91
Applying radiation protection and safety in radiotherapy 91
Aspetti Clinici e farmacoeconomici di Loramyc miconazolo in compresse buccali mucoadesive nella candidosi orofaringea del paziente immunodepresso. un'analisi di budget impact per l'Italia 90
What is the most effective treatment for head and neck squamous cell carcinoma?An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups. 90
A new in vitro model system to study antimycotic drugs. 89
Radiotherapy after high-dose chemotherapy followed by autologous bone marrow transplantation in patients with intermediate or high-grade non-Hodgkin's lymphoma. 88
What is the standard in Platinum-based radiochemotherapy in H&N? 88
Tumor size-driven dose of intraoperative radiotherapy for breast cancer: 18 Gy versus 21 Gy 88
Totale 10.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.559
article - articoli 66.768
book - libri 630
conference - conferenze 16.178
curatela - curatele 1.536
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.447
Totale 183.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.365 0 0 0 388 589 727 1.448 439 660 1.739 1.052 323
2020/20212.044 115 136 144 119 97 244 111 210 255 246 170 197
2021/20224.698 115 392 141 616 255 405 288 1.060 226 421 131 648
2022/20234.208 489 120 81 353 764 832 15 316 752 12 409 65
2023/20241.868 99 328 47 199 163 306 99 81 117 33 104 292
2024/20251.064 85 602 186 191 0 0 0 0 0 0 0 0
Totale 29.344